Searched for
US DRUGMAKER MERCK
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Merck to partner with Google Cloud on AI initiativesDrugmaker Merck & Co is joining forces with Google Cloud. They will invest up to one billion dollars over several years. This partnership a...
- Trump administration readies new tariffs on select drugmakers: ReportThe Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- Merck & Co to create a separate cancer unit as patent cliff loomsMerck & Co is restructuring by splitting its drug division into two separate businesses. The change is designed to spotlight its fastest-gr...
- TrumpRx explained: How Trump’s new drug price deals with 9 pharma companies could save patients moneyTrumpRx: President Donald Trump has struck new deals with nine major drug companies. These agreements aim to reduce prescription drug price...
- Merck nears $10 bn deal for respiratory drugmaker Verona: ReportsMerck is close to buying Verona Pharma, a biotech firm specializing in lung diseases. The deal is valued at around $10 billion. Merck aims ...
- US drugmaker Merck to boost workforce in India, executive saysMerck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employe...
- Daiichi Sankyo, Merck ink $22-billion cancer drug dealThe deal adds promising drug candidates to Merck's oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expir...
- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...
- Sun Pharma Q2 net profit up 15% at Rs 1,572 crore"We also continue to review opportunities to expand and strengthen our global footprint,” said Dilip Shanghvi, managing director, Sun Pharm...
- Hilleman Laboratories loses key executivesSome of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.
- Merck, Sun Pharma ink JV to bring innovative drugs to EMsSun Pharmaceutical will bring its product development skills to the table, while Merck will help with market presence.
- Merck to acquire SmartCells for USD 500 mnDrug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
- Drugmaker Merck closing 8 plants, 8 research sitesDrugmaker Merck & Co. said Thursday it is shutting down eight manufacturing plants and eight research sites around the world, including two...
- Merck, Glenmark end cholesterol drug rowCos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.
- Merck to launch 13 innovator drugs hereUS-based Merck plans to launch 13 innovator drugs, including a blockbuster product in India, over the next two-three years.
Load More
